Viewing Study NCT03452592


Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2026-01-04 @ 5:37 PM
Study NCT ID: NCT03452592
Status: TERMINATED
Last Update Posted: 2025-04-03
First Post: 2018-02-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients With T790M
Sponsor: Allist Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module